Skip to search formSkip to main contentSkip to account menu

telmesteine

Known as: 3-ethylhydrogen-3,4-thiazolidinedicarboxylate, telmestein 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Thiazolidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Evidence-based treatment of atopic dermatitis with topical moisturizers.
Skin barrier restoration represents the mainstay of the treatment of atopic dermatitis and the use of moisturizers is recommended… 
2009
2009
Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent.
Atopiclair (Zarzenda) is a topical non-steroidal anti-inflammatory agent for the treatment of allergic diseases of the skin… 
2008
2008
Telmesteine exerts an anti-protease activity suitable in the therapy of psoriasis
2007
2007
Atopiclair™: its position within a topical paradigm for the treatment of atopic dermatitis
Atopiclair™ and Zarzenda™ (glycyrrhetinic acid/telmesteine/Vitis vinifera) are the brand names for a new topical agent for the… 
Review
2006
Review
2006
Steroids versus other immune modulators in the management of allergic dermatoses
Purpose of review The classic role of topical and systemic corticosteroids for allergic dermatoses is discussed, with special… 
Highly Cited
2005
Highly Cited
2005
A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis.
MAS063D (Atopiclair is a hydrolipidic cream that has been developed for the management of atopic dermatitis (AD). The putative… 
2003
2003
Absorption, distribution, metabolism and excretion of telmesteine, amucolitic agent, in rat
1. The metabolism and disposition of telmesteine, a muco-active agent, have been investigated following single oral or… 
1994
1994
[Telemestein and variations in blood concentrations of lipoprotein A].
Twenty patients with high serum levels of Lp(a) were randomly treated with 900 mg/day telmestein or placebo. We found, in those… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)